Contents of this document
- Special factors in the previous fiscal year
- Net sales-16
- Cost of sales-4
- Selling, general and administrative expenses-22
- Impact of U.S. tariffs-29
- Improvement measures, etc.22
- Foreign exchange and other factors
- USD exchange rate¥150
- EUR exchange rate¥170
- USD foreign exchange sensitivityFor each ¥1 appreciation/depreciation of the yen: revenue, approximately ¥500 million; operating profit, approximately ¥16 million
- EUR foreign exchange sensitivityFor each ¥1 appreciation/depreciation of the yen: revenue, approximately ¥300 million; operating profit, approximately ¥5 million
- Decision to establish a base in Dubai
- Participation in Together for Sustainability (TfS)
- Reduction of cross-shareholdings
- Project to recreate the fragrance of Ranjatai, a legendary incense
- Publication of an analyst report by Shared Research
- ROE6.4 %Year on year against the same period last year-3.4%
- ROIC2.7 %Year on year against the same period last year-3.4%
- Equity ratio56.6 %Year on year against the same period last year+1.6%
- D/E ratio39.7 %Year on year against the same period last year+1.3%
- PBR0.75 timesYear on year against the same period last year-0.4%
- Net salesTarget fiscal yearFinal year of NGP-2
- Operating marginTarget fiscal yearFinal year of NGP-2
- ROETarget value8% or higherTarget fiscal yearFinal year of NGP-2
- DOETarget valueAt least 3.0%Target fiscal yearNGP-2 period
- Payout ratioTarget valueAt least 30%Target fiscal yearNGP-2 period
- -50 Hundreds of millions of yenDetailsImpact of the situation in the Middle East
- 0 Hundreds of millions of yenDetailsIncludes improvement measures and other actions addressing the impact of US tariffs
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Fiscal year ending March 2026, full year |
| Net Sales | 2,251 Hundreds of millions of yen (YoY -1.8%) |
| Operating profit | 81 Hundreds of millions of yen (YoY -47.0%) |
| Ordinary income | 95 Hundreds of millions of yen (YoY -37.9%) |
| Net income | 95 Hundreds of millions of yen (YoY -28.5%) |
| Gross Profit Margin | 32.4 |
| Operating profit margin | 3.6 |
| Selling, general and administrative expenses | 648 Hundreds of millions of yen |
| Results for the three months of the current quarter | Net Sales Fourth quarter of the fiscal year ended March 2026 536 Hundreds of millions of yen / Operating profit Fourth quarter of the fiscal year ended March 2026 7 Hundreds of millions of yen |
| Full-year earnings forecast | Fiscal year ending March 2027 Net Sales 2,400 Hundreds of millions of yen / Gross profit 801 Hundreds of millions of yen / Operating profit 110 Hundreds of millions of yen / Ordinary income 115 Hundreds of millions of yen / Net income 94 Hundreds of millions of yen |
| Self-assessment against the plan | For the fiscal year ended March 2026, exceeded the NGP-2 plan |
| Segment results | Japan Net Sales 770 / Operating profit 6 / Year-on-year change in revenue 4.6 / Year-on-year change in operating profit -39 / Americas Net Sales 556 / Operating profit 9 / Year-on-year change in revenue -16.5 / Year-on-year change in operating profit -17 / Europe Net Sales 424 / Operating profit 8 / Year-on-year change in revenue 7.9 / Year-on-year change in operating profit -17 / Asia Net Sales 502 / Operating profit 57 / Year-on-year change in revenue 0.8 / Year-on-year change in operating profit 7 / Adjustments Net Sales Not disclosed / Operating profit 2 / Year-on-year change in operating profit -7 |
| Breakdown of Factors Affecting the Change | Factors Special factors in the previous fiscal year / Amount Not disclosed, Factors Net sales / Amount -16, Factors Cost of sales / Amount -4, Factors Selling, general and administrative expenses / Amount -22, Factors Impact of U.S. tariffs / Amount -29, Factors Improvement measures, etc. / Amount 22, Factors Foreign exchange and other factors / Amount Not disclosed |
| Key KPIs | Indicator name ROE / Value 6.4 % / Year on year against the same period last year -3.4 %, Indicator name ROIC / Value 2.7 % / Year on year against the same period last year -3.4 %, Indicator name Equity ratio / Value 56.6 % / Year on year against the same period last year 1.6 %, Indicator name D/E ratio / Value 39.7 % / Year on year against the same period last year 1.3 %, Indicator name PBR / Value 0.75 times / Year on year against the same period last year -0.35 times |
| Assumptions Underlying the Business Outlook | Item USD exchange rate / Value ¥150, Item EUR exchange rate / Value ¥170, Item USD foreign exchange sensitivity / Value For each ¥1 appreciation/depreciation of the yen: revenue, approximately ¥500 million; operating profit, approximately ¥16 million, Item EUR foreign exchange sensitivity / Value For each ¥1 appreciation/depreciation of the yen: revenue, approximately ¥300 million; operating profit, approximately ¥5 million |
| Risk amount incorporated into the outlook | Details Impact of the situation in the Middle East / Amount -50 Hundreds of millions of yen, Details Includes improvement measures and other actions addressing the impact of US tariffs / Amount 0 Hundreds of millions of yen |
| Medium-term management plan targets | Item Net sales / Target value Not disclosed / Target fiscal year Final year of NGP-2, Item Operating margin / Target value Not disclosed / Target fiscal year Final year of NGP-2, Item ROE / Target value 8% or higher / Target fiscal year Final year of NGP-2, Item DOE / Target value At least 3.0% / Target fiscal year NGP-2 period, Item Payout ratio / Target value At least 30% / Target fiscal year NGP-2 period |
| Financial targets | ROE Target At least 8.0% / Actual results for the fiscal year ending March 2026 6.4% / Equity ratio Target 55% (final year) / Actual results for the fiscal year ending March 2026 56.6% / DOE Target At least 3.0% / Actual results for the fiscal year ending March 2026 3.4% / Payout ratio Target At least 30% / Actual results for the fiscal year ending March 2026 53.2% |
| Annual Dividend | Forecast for the fiscal year ending March 2027 Annual ¥52 / Interim ¥26 / End of period ¥26 / Actual results for the fiscal year ending March 2026 Annual ¥260 on a pre-split basis, ¥52 on a post-split basis / Interim ¥120 / End of period ¥28 |
| Payout ratio | Actual results for the fiscal year ending March 2026 53.2 % / Forecast for the fiscal year ending March 2027 53.9 % / DOE Actual results for the fiscal year ending March 2026 3.4 % / Forecast for the fiscal year ending March 2027 3.3 % |
| Capital expenditures | ¥217 100 million (actual for the fiscal year ended March 2026) |
| New initiatives | Decision to establish a base in Dubai, Participation in Together for Sustainability (TfS), Reduction of cross-shareholdings, Project to recreate the fragrance of Ranjatai, a legendary incense, Publication of an analyst report by Shared Research |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, shipments of flavors, fragrances and fine chemicals declined at the US subsidiary, while fragrance shipments also declined at the French subsidiary due to shipment adjustments associated with the introduction of a new core system. In addition, higher procurement costs due to foreign exchange movements, rising raw material prices, higher SG&A expenses associated with strengthening the sales and administrative structure, and postponed shipments of pharmaceutical intermediates weighed on profit. For the fiscal year ending March 2027, the company expects higher sales of pharmaceutical intermediates for Europe and the US, flavors for emerging markets, and fragrances in the Americas and Asia.